Kaplowitz N , Lewis JH , Watkins P.Did this drug cause my patient’s hepatitis?Ann Intern Med2003; 138(2): 159-160 .
4.
Kennedy D.An epidemic of politics . Science2003; 299: 625-625 .
5.
Steinbrook R.Science, politics, and federal advisory committees . New Engl J Med2004; 350: 1454-1460 .
6.
Frankfurt HG.On bullshit. Princeton University Press , 2005: 64-65.
7.
Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies, 2004: 1-76. Retrieved from http://www.nih.gov/about/ethics_COI_panelreport.pdf
8.
National Research Council . Health risks from dioxin and related compounds: evaluation of the EPA reassessment. National Research Council , 2006: 163-164.
9.
Health Risks from Dioxin and Related Compounds: Evaluation of the EPA Reassessment. (2006) National Research Council . ISBN: 0-309-10258, pp. 163-164.
10.
Siwek J , Gourlay ML , Slawson DC , Shaughnessy AF.How to write an evidence-based clinical review article . Am Fam Phys2002; 65(2): 251-258 .
11.
Egger MS , Ebrahim Smith GW.‘Where now for meta-analysis?’Int J Epidemiol2002; 31(1): 1-5 .
12.
Lotti M , Nicotera P.Toxicology: a risky business . Nature2002; 416: 481-481 .
13.
Mallett S , Clarke. M.How many Cochrane reviews are needed to cover existing evidence on the effects of health care interventions?ACP J Club2003; 139(1): A11-A11 .